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Nitric oxide (NO) deficiency represents a known feature of cardiovascular and metabolic 
diseases as well as natural aging. The NO metabolites nitrate and nitrite have long been 
considered as health-threatening food components with potential carcinogenic effects. 
Surprisingly, more recent research has demonstrated that boosting of a nitrate-nitrite-NO 
pathway via the diet (mainly green leafy vegetables and beetroot) improves cardiovascular 
function, mitochondrial efficiency and reduces oxidative stress.  
The aim of this thesis was to explore the effects of inorganic nitrate and nitrite with respect 
to metabolic dysfunction, when this is driven by either unbalanced diets or natural aging. At 
the same time, we sought to clarify whether the microbiota is an indispensable factor for the 
bioactivation of dietary nitrate, its cardiometabolic effects as well as the onset of diet-induced 
obesity.  
We demonstrate that inorganic dietary nitrite extends the lifespan of female fruit flies and 
protects them from age-dependent locomotor decline, thus promoting healthspan. Moreover, 
nitrite could lower glucose and triglycerides levels in aged female flies. This, together with 
modulation of dTOR and dSir2 gene expression, indicates that nitrite might benefit 
metabolism during aging by regulating the sensing of nutrients. Furthermore, we show the 
existence of a nitrite-NO pathway, to which the fly bacteria likely contribute. Similarly, we 
prove the obligatory role of the host microbiota in bioactivation of dietary nitrate in 
mammals. In a mouse model of cardio-metabolic dysfunction, we described blood pressure-
lowering and anti-diabetic effects as well as protection from hepatic steatosis by dietary 
nitrate, in the presence of a conventional microbiota. However, when the same disease model 
was reproduced in germ-free mice, carrying no bacteria, none of these salutary effects of 
nitrate was achieved. While attributing the cardiometabolic benefits of inorganic nitrate to 
the host microbiota, in a separate study we show that no such obligatory relationship underlies 
the general onset of diet-induced obesity. This finding is in stark contrast to the current 
literature which suggests a causal role of gut bacteria in fat storage.  
In conclusion, we here describe previously unknown metabolic effects of dietary nitrate and 
nitrite which are dependent on the host microbiota. In addition, we show that diet-induced 
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1.1 ENZYMATIC SYNTHESIS, SIGNALING AND BIOLOGICAL FUNCTIONS OF 
NO 
Nitric oxide (NO) is endogenously produced by NO synthases (NOSs). These exist in three 
isoforms (nNOS, iNOS and eNOS), which catalyse NO production via an oxygen-dependent five-
electron-transfer reaction from the amino acid L-arginine. Such reaction requires a number of 
cofactors and eventually results in equimolar amounts of NO and L-citrulline [1].  
Once NO is formed, this reactive free radical gas is rapidly oxidized forming nitrate and nitrite. In 
blood, NO reacts with oxyhaemoglobin generating nitrate and methaemoglobin, whereas in tissues 
some nitrite is formed as well [1]. Therefore, plasma levels of nitrate in humans are typically higher 
than nitrite levels i.e. 20-40 µM and 50-300 nM respectively [2,3]. 
Being one of the most ubiquitous signaling molecules in mammals, NO activates numerous 
downstream pathways. The most important of these, is perhaps the stimulation of soluble guanylyl 
cyclase (sGC), leading to production of 3´-5´- cyclic guanosine monophosphate (cGMP) which 
then activates cGMP-dependent protein kinase (PKG).  
This specific signaling pathway is responsible for many of the biologic functions of NO, both at 
the organ and cellular level. For instance, it mediates relaxation of vascular smooth muscle and 
platelet aggregation in the cardiovascular system [4,5]. It also triggers angiogenesis and plays an 
important role in the immune- [6,7] and nervous systems [8,9]. At the cellular level, NO broadly 
affects mitochondria and their function. Its reversible binding to cytochrome c oxidase is 
responsible for reduced mitochondrial respiration. At the same time, NO targets complex I of the 
electron transport chain through S-nitrosation, resulting in reduced generation of mitochondrial 
reactive oxygen species (ROS) [10–12]. Moreover, by decreasing the expression of mitochondrial 
proteins that regulate proton leakage, NO also improves mitochondrial efficiency [13].  
In 1994, two groups independently discovered that NO formation does not necessarily require NOS 
enzymes. Instead, salivary nitrite was identified as the source of NO, resulting from nitrite 
protonation to HNO2 in the acidic gastric milieu and further decomposition to form NO and other 
reactive nitrogen oxides [14,15]. Following this line of evidence, systemic NO generation from 
nitrite was reported soon after in the ischemic heart [16]. In this study as in others [17,18], NO 
formation from nitrite was once again due to the acidic conditions (pH < 5 in the ischemic mouse 
heart). Subsequent studies demonstrated the existence of several other pathways for nitrite 
reduction in vivo. These involve deoxy-haemoglobin, deoxy-myoglobin, xanthine oxidoreductase, 
protons as well as reductants such as vitamin C and polyphenols [19]. Interestingly, whereas the 
enzymatic synthesis of NO is oxygen dependent, nitrite reduction to NO is greatly favoured by 
hypoxia. As such, we should consider NOS independent NO formation as a backup system that 
helps maintaining NO homeostasis when the NOS enzymes might not be fully functional [20,21]. 
In support of this view, the administration of nitrite and its precursor nitrate, possess known 




1.2 NO GENERATION FROM THE DIET: THE NITRATE-NITRITE-NO PATHWAY 
Inorganic nitrate is abundant in green leafy vegetables (spinach, rucola, lettuce) and red beets 
[24]. It is estimated that a plate of vegetables provides more nitrate than what is formed daily by 
the combination of all three NOS enzymes  [25]. Thus, dietary intake of this anion can be 
considerable.  
When nitrate is ingested, it is rapidly absorbed in the gastrointestinal tract and enters the 
circulation. Here, its concentration typically peaks after 30 minutes from ingestion and its half-
life is about 5-6 hours. While most of the circulating nitrate is eventually excreted via the kidneys, 
as much as 25% is efficiently taken up by the salivary glands and concentrated in saliva. In the 
oral cavity, nitrate is reduced to nitrite by commensal anaerobic bacteria [24,26]. Swallowed 
nitrite enters the acidic gastric environment where it is immediately protonated, forming nitrous 
acid (HNO2), which in turn forms NO and other nitrogen oxides [14,15] through a non-enzymatic 
reaction (so called disproportionation). This process is referred to as “the entero-salivary nitrate 
circulation” (Figure 1).  
 




After a nitrate-rich meal, salivary nitrate levels can approach 10 mM whereas nitrite concentrations 
are about 10 times lower, ranging from 1 to 2 mM [3]. Thus, salivary levels of nitrate and nitrite 
are orders of magnitude higher than in normal plasma. This remarkable difference speaks in favour 
of a pivotal role of the enterosalivary nitrate circulation in preserving NO homeostasis. Therefore, 
inorganic nitrate supplementation has emerged as a valid alternative source of NO, offering dietary-
based opportunities for possible treatment and prevention of some of the most common cardio-
metabolic disorders arising from reduced NO synthesis/bioavailability [22]. 
1.3 BIOACTIVATION OF DIETARY NITRATE 
Despite its described salutary effects on blood pressure and metabolism [23,27], inorganic nitrate 
is likely in itself an inert anion. To achieve the suggested health benefits associated with its intake, 
a bioactivation process is needed, ultimately forming biologically active NO and other reactive 
nitrogen oxides. The bioactivation of dietary nitrate starts in the oral cavity, where commensal 
facultative anaerobic bacteria use nitrate as an alternative electron acceptor to form ATP when 
oxygen is scarce or to build biomass [26,28,29]. In this process the product is nitrite, an anion 
much more reactive than nitrate. 
In 2004, Lundberg and Govoni described for the first time an elevation in plasma nitrite after nitrate 
ingestion. Interestingly, disruption of the enterosalivary circulation by avoiding swallowing during 
a 2 hours period after the nitrate intake, could prevent the plasma nitrite increase in the same 
individuals [3]. The implication of oral bacteria in this process was established four years later, 
when the same authors showed that this remarkable elevation in circulating nitrite was nearly 
abolished by a mouth rinse with an antiseptic mouthwash, immediately before the nitrate load [28]. 
The physiological importance of bacterial nitrate reduction and its relevance to cardiovascular 
health was later demonstrated by a number of studies [30–33].  
Once nitrate has been bioactivated forming nitrite, a second reduction reaction is needed to generate 
NO and other nitrogen oxides [34,35]. This final step can also be considered a bioactivation process 
happening further down in the gastrointestinal tract, specifically in the stomach. As described 
above, the acidic pH appears to be the main driver in gastric NO formation from nitrite. In fact, 
when increasing gastric pH with proton pump inhibitors in rats, Pinheiro et al. found attenuation of 
the blood-pressure reducing effects of nitrite [36]. This observation was recently confirmed in 
humans [37].  
1.4 DIETARY NITRATE AND THE ORAL MICROBIOTA 
The relationship between NO and bacteria is complex, yet fascinating. Among its very many 
biological functions, NO represents an important player in host immune defence. NO production 
is in fact, one of the major antimicrobial strategies of macrophages [38] and few bacterial strains 
can survive a heavy NO exposure [39–41]. As an example, nitrite-dependent NO production in the 
stomach provides protection against potentially ingested enteropathogens [14,15,42]. Although 




in the presence of nitrite [42]. Ironically, at the same time, the generation of NO in the stomach 
requires oral bacteria to produce nitrite from salivary nitrate in the first place. In fact, in germ-free 
(GF) rats, gastric NO formation is absent even after a nitrate load [43].  
Bacterial bioactivation of nitrate is crucial for the physiologic effects and therapeutic potential of 
nitrate/nitrite-derived NO. One example is the effect of ingested nitrite on gastric mucus thickness 
and blood flow. In 2004, Björne et al. found that topical application of human nitrite-rich saliva 
(obtained after ingestion of nitrate) on the rat gastric mucosa, increases mucus thickness and blood 
flow [44]. The same effect was achieved in rats after 7 days with nitrate addition to drinking water. 
Clearly these effects of nitrate-derived NO play a physiologic role in maintaining gastric integrity, 
conferring protection against gastric injury [45]. However, such beneficial effect is lost in a rodent 
model of stress-induced gastric injury, if the oral flora is depleted [46]. Hence, the obligatory role 
of oral bacteria in ensuring the gastroprotective effects of nitrate-derived NO. The importance of 
this bioactivation process is reflected by the clinical complications seen in intubated patients, 
whose enterosalivary nitrate circulation is disrupted for a prolonged time. In these patients, 
insufficient levels of gastric NO are thought to contribute to gastric lesions and bacterial 
overgrowth [47]. 
Most studies investigating the role of nitrate-reducing oral bacteria, focused on the cardiovascular 
consequences of disrupting the nitrate-nitrite-NO pathway [28,30–33,48,49]. In a classic study by 
Petersson and Carlström, rats were pre-treated for 7 days with an antiseptic mouthwash before 
receiving nitrate in the drinking water for one week. As a result, bacterial depletion effectively 
blunted the blood pressure-lowering action of nitrate, which was otherwise clear when animals 
were not treated with a mouthwash [30]. Further, in two separate human studies, an antiseptic 
mouth-rinse reduced the nitrate to nitrite reduction, affecting blood pressure. These studies suggest 
that recycling of endogenous nitrate is sufficient to generate enough NO-bioactivity for 
physiological modulation of blood pressure [31,33]. In this salvage pathway oral bacteria play an 
important role. 
However, mammalian enzymatic routes are also known to contribute to nitrate and nitrite 
reduction. One example is the mammalian xanthine oxidoreductase (XOR). In 2008, Jansson et al. 
suggested a role for this enzyme in reducing nitrate to nitrite in vivo, under normoxic conditions. 
Following systemic nitrate administration in GF mice, they noted a marked elevation in plasma 
nitrite levels that was attenuated by the XOR inhibitor allopurinol [50]. Indeed, this enzyme might 
play an important role in bioactivation of nitrate under certain conditions (i.e. hypoxia) or within 
specific tissues where it is highly expressed (i.e. white adipose tissue). Nonetheless, the 





1.5 THE ROLE OF THE GUT MICROBIOTA IN METABOLIC HEALTH AND 
POSSIBLE INTERACTIONS WITH DIETARY NITRATE 
In the past decades, obesity has become a health and social burden to be urgently addressed [51] 
and researchers around the globe are joining forces to better understand the pathophysiology of this 
systemic disease, aiming at more successful treatment strategies. To this respect, one major subject 
of investigation is the gut microbiota.  
In 2004, it was observed that GF mice, carrying no bacteria, appear leaner than conventional 
(CONV) mice with a normal microbiota. Moreover, GF mice colonized with the faecal microbiota 
of CONV mice, gain weight and show increased fat mass, fasting blood glucose and insulin levels 
[52]. This was the first evidence of a potential mechanistic involvement of the gut microbiota in 
energy harvest from the diet and fat storage. In support of these findings, later reports from the 
same group and others, described protection of GF mice from diet-induced obesity [53–55] as well 
as an aberrant, obesity-specific gut microbiome [56,57]. These studies triggered intense research 
efforts investigating host-bacterial interactions in the regulation of metabolism and ultimately 
weight control. Currently, a key question in the field is whether we should consider the microbiota 
as a causal factor in the pathophysiology of obesity [58,59]. 
Supporting the idea of a causal link, faecal microbial transplantation studies have shown that the 
obese phenotype can be transferred from ob/ob mice [56] but also obese individuals [60] to 
previously healthy GF mice. Nonetheless, clear evidence supporting such hypothesis in humans is 
still missing [59,61] and some animal studies suggest that the absence of bacteria does not always 
protect against obesity [62–65]. 
More recently, we have appreciated the greater metabolic impact of a balanced gut microbial 
ecology over strain-specific bacterial modifications. Loss of this balance, a state termed 
“dysbiosis”, has been associated with both metabolic [66,67] and cardiovascular dysfunction 
[68,69]. To this end, one major influencing factor of the gut microbiota is the everyday diet [70].  
Generally, diets rich in fiber such as the Mediterranean diet, have been associated with reduced 
incidence of metabolic diseases [71]. According to recent research, these diets shape the gut 
microbiota and such changes seem to be involved in their salutary metabolic outcomes (i.e. lowered 
circulating triglycerides and glucose) [72,73]. 
Animal studies suggest that supplementation with dietary nitrate could be a promising intervention 
to modulate metabolism and prevent metabolic dysfunction, especially when driven by high 
fat/high sugar diets [23,74]. It is logical to consider if an interaction could exist between inorganic 
nitrate (and its metabolites) and the gut microbiota. 
Research addressing this question has so far been very limited. On one hand, it is believed that 
relevant amounts of dietary nitrate would never reach the lower gastrointestinal tract - where most 
bacteria reside - due to its complete absorption in the upper intestine [75]. In support of this view, 
studies have shown no changes in faecal microbial structure in rats after nitrate supplementation  
[76,77]. On the other hand, reduced Firmicutes to Bacteroidetes ratio (opposite to what is known 
being a sign of dysbiosis) was reported in healthy individuals after three days supplementation with 




preventing gut dysbiosis. Furthermore, very recent research has indicated amelioration of dysbiosis 
by nitrate in mouse models of colitis [79] and diet-induced obesity [80]. The reverse has also been 
shown: prolonged consumption (18 months) of a nitrate depleted diet leads to dysbiosis as well as 
severe metabolic and cardiovascular dysfunction in mice [81].  
Thus, a previously unexpected interplay between gut bacteria and the metabolic benefits of nitrate 
is coming to light. In the future, studies might clarify the specific action of nitrate-rich diets on gut 
microbial composition as well as the effects of any such modification, with particular respect to 
metabolic diseases but also lifestyle factors (i.e. physical activity, specific dietary regimens, anti-
diabetic/obesity medications).  
1.6 DIETARY NITRATE AS A MODULATOR OF METABOLIC FUNCTION  
A role of NO in maintaining metabolic homeostasis became clear when in 1995, Huang et al. found 
that mice lacking eNOS do not develop hypertension exclusively, but also metabolic dysfunction 
with increased abdominal fat, dyslipidaemia and glucose intolerance [82]. In humans, 
polymorphisms in the eNOS gene have been associated with type 2 diabetes (T2D) [83] and these 
patients also seem to generate less NO from L-arginine, as compared to healthy subjects [84,85]. 
Similar effects are seen following chronic NOS inhibition [86]. If NO is such a crucial molecule 
for maintaining a healthy metabolism, would then nitrate supplementation prevent or restore 
impaired metabolic function? Carlström et al. addressed this question by supplementing aged  
eNOS-/- mice with inorganic nitrate at a similar amount to what has been estimated to be produced 
endogenously by eNOS [87]. After receiving nitrate in the drinking water for 8-10 weeks, the 
metabolically compromised eNOS deficient mice showed improved glucose tolerance, reduced 
plasma triglycerides, lower glycated haemoglobin (HbA1c) as well as reduced weight gain 
accompanied by reduced adiposity. Thus, replenishment of NO bioactivity via dietary nitrate could 
reverse a metabolic syndrome-like phenotype, supporting the idea of NO as an important modulator 
of metabolism.  
Two years after these findings, Nyström and colleagues found increased pancreatic blood flow and 
insulin release by inorganic nitrite administered acutely [88], providing further evidence of  
antidiabetic effects of nitrite-derived NO. In the following years, the antidiabetic effects of 
stimulating the nitrate-nitrite-NO pathway were studied in various animal models of T2D and 
metabolic syndrome. In a rat model of fructose-induced T2D, Essawy et al. reported decreased 
mean arterial blood pressure, improved insulin resistance and decreased adipose tissue index, both 
when nitrate was administered as a preventive and as a therapeutic intervention, with the greater 
effects in the first model [89]. Later, another study employed a rat model of T2D induced by 
streptozocin and nicotinamide. In these animals, the low levels of circulating nitrate and nitrite 
were restored by nitrate supplementation in the drinking water. At the same time, nitrate improved 
the animals´ metabolic function (glycemia, lipid profile, glucose tolerance) [90]. Similar results 
were obtained with chronic oral nitrite administration in a rat model of metabolic syndrome with 




Most importantly, chronic dietary nitrate supplementation has proven effective also when 
obesity, T2D [92,93] and hepatic steatosis [94] were induced by calorie dense diets. Conversely, 
wild type mice depleted of nitrate and nitrite from the diet, developed a similar phenotype of that 
seen in eNOS-/- mice: metabolic syndrome, endothelial dysfunction and even premature cardiac 
death developing over time (18-22 weeks) [81]. 
Despite the fact that antidiabetic effects of nitrate/nitrite have been widely described in animal 
models of obesity and T2D [89–93,95–97], evidence is still lacking in humans. Only one short 
study was performed in T2D patients, reporting no changes in blood pressure nor improved 
endothelial function or insulin sensitivity after two weeks beetroot juice (BRJ) intake [98]. 
The molecular mechanisms behind the salutary metabolic effects of dietary nitrate are 
progressively being revealed. The insulinotropic effect of nitrite described in the Nyström study, 
was cGMP dependent [88]. However, some later studies indicate other, cGMP-independent 
mechanisms.  
Glucose transporter type 4 (GLUT4) facilitates the transport of glucose into the cell, representing 
a crucial regulator of whole body glucose homeostasis [99]. Nitrite has been shown to induce 
translocation of GLUT4 both in vitro [97] and in vivo [100], indicating increased glucose uptake 
by nitrite-generated NO. Similarly, Gheibi et al. found that nitrite supplementation for 8 weeks, 
stimulates insulin secretion and increases insulin content in the rat pancreatic islets. In the same 
study, nitrite increased GLUT4 levels in soleus muscle and epididymal adipose tissue in obese, 
T2D rats [101]. In a separate study, the same group reported similar effects with chronic nitrate 
supplementation in diabetic rats, together with decreased gluconeogenesis, ROS production and 
inflammation [93]. Again, Lai et al. showed GLUT4 translocation in skeletal muscle of obese 
rats following oral administration of inorganic nitrate and nitrite [91]. The proposed mechanisms 
for GLUT4 translocation are various. In their in vitro study, Jiang and colleagues indicated NO 
derived from nitrite to cause S-nitrosation of GLUT4, thus facilitating its translocation to the 
membrane of skeletal muscle cells [97]. On the other hand, Lai et al. suggested SIRT3-AMPK 
activation by long-term nitrite treatment. Activated AMPK would then drive GLUT4 
translocation to the plasma membrane of skeletal muscle cells, improving insulin-independent 
glucose uptake [91].  
AMPK is an important cellular energy sensor and its activation is repressed in diet-induced 
obesity and T2D [102,103]. Thus, restoration of AMPK activity is regarded as a promising 
approach for the treatment of such diseases [104–107]. Indeed, AMPK activation by dietary 
nitrate has been reported by several studies using animal models of obesity and diabetes [91,95] 
as well as in human skeletal muscle fibers from T2D subjects [91]. However, the exact 
mechanisms of AMPK activation by nitrate/nitrite are debated [108]. One possibility entails a 
change in cellular energy status triggered by the interaction between the nitrate-derived nitrogen 
oxide species and the mitochondrial respiratory chain [109].  
Newer molecular insights into the metabolic effects of nitrate indicate that short term 
supplementation with this anion enhances the expression of thermogenic genes and induces 




oxidation in vivo [110]. These findings have been recently reproduced in a rat model of T2D 
following chronic nitrate intake [111]. Of note, browning of adipose tissue has recently emerged 
as a promising strategy for counteracting obesity and T2D [112,113].  
The adipose tissue has gained increasing attention as a metabolic organ greatly involved in 
insulin sensitivity. As a matter of fact, both the skeletal muscle and the white adipose tissue 
(WAT) are important sites of glucose disposal. XOR is a known nitrate/nitrite reducing enzyme 
that is highly expressed in white adipocytes. In a recent report, XOR-mediated nitrate reduction 
is indicated as a mechanism for the increased WAT glucose uptake and oxidative catabolism in 
nitrate-supplemented rats [114]. The actions of inorganic nitrate on WAT are worth further 
research efforts as they might play an important role in the antidiabetic effects of this anion. 
At the cellular level, an important player in the metabolic effects of nitrate is the mitochondrion. 
The interaction between endogenous NO and this organelle is well established [23,108,115]. 
Already in 1994, nanomolar concentrations of NO were shown to compete with oxygen and 
reversibly bind cytochrome c oxidase, inhibiting mitochondrial respiration [12] and resulting in 
reduced mitochondrial ROS production [116]. However, later research has demonstrated that 
NO and other nitrogen species derived from the nitrate-nitrite-NO pathway, may interact with 
mitochondria also in other ways [23,108].  
In 2011, Larsen and colleagues found reduced mitochondrial proton leak in skeletal muscle 
biopsies from healthy subject following a 3-day nitrate intervention. This effect observed in 
vitro, was positively correlated with decreased whole-body oxygen consumption during exercise 
in the same subjects. Ultimately, this study demonstrated that even a short supplementation 
period with dietary nitrate improves mitochondrial efficiency in humans, increasing the amount 
of energy produced per oxygen consumed [13]. Accordingly, earlier reports from the same group 
had shown reduced oxygen cost (VO2) during exercise, following sodium nitrate intake (0.1 
mmol/kg/day for 3 days) in healthy volunteers [117]. Similar effects were reported with BRJ as 
a source of nitrate (3 days intervention in healthy subjects), proving that dietary sources of nitrate 
are equally efficacious [118]. Thereafter, the exercise-enhancing abilities of dietary nitrate were 
reported by a number of studies [13,117–122].  
However, a lack of ergogenic effects by nitrate has been described as well [123–125]. The main 
difference between positive and negative findings being the training status of the subjects.  The 
proposed reasons are various. For instance, consistent training increases muscle oxygenation 
efficiency, likely limiting nitrite reduction. Moreover, athletes present a higher proportion of 
type I muscle fibers, which seem to respond less to nitrate supplementation [126]. Nonetheless, 
circulating nitrate and nitrite appear to be higher in well trained subjects compared to non-
athletes [127,128]. This might suggest that a well efficient NOS system is sufficient for optimal 
NO homeostasis, making nitrate supplementation unnecessary. Similarly, a longer nitrate 
supplementation via BRJ, while maintaining ergogenic abilities, does not lead to any greater 




If nitrate supplementation seems less effective in elite athletes, it might instead represent a valid 
supplement in situations of reduced mobility due to diseases or the old age. The potential 
therapeutic benefits of nitrate supplementation will be discussed in the following paragraph. 
1.7 DIETARY NITRATE AND METABOLIC DECLINE DURING AGING 
In the last two centuries, we have seen life expectancy nearly doubling. However, the length of 
disease-free lifespan (healthspan) has not been as greatly extended [129], making age-related 
pathologies some of the most urgent social and economic burdens to be addressed.  
Aging represents the major risk factors for cardio-metabolic diseases and it is associated with 
reduced NO bioavailability and synthesis [130]. Thus, restoration and maintenance of NO 
homeostasis via nitrate supplementation represents an appealing strategy to address age-related 
physiological decline.  
Following the discovery of the ergogenic abilities of inorganic nitrate, several studies 
investigated whether nitrate supplementation would improve mobility in older adults. In most of 
these works subjects were affected by pathologies such as peripheral artery disease [131], 
obstructive pulmonary disease (COPD) [132–135] or heart failure with preserved ejection 
fraction [136–138]. Although two of the COPD studies could not detect any effect of BRJ on 
physical performance [133,139], the overall outcome of these relatively small trials indicates a 
beneficial role of inorganic nitrate on physical function, together with additional cardiovascular 
benefits [137]. 
Similar studies in healthy older individuals are so far scarce. In the first two reports on this type 
of subjects, nitrate supplementation did not improve functional capacity (walking test, timed up-
and-go test and hand-grip test) [140,141] and in a more recent study, no effects of nitrate were 
detected on exercise tolerance in middle aged-older subjects [142].  
Such lack of effect in healthy older adults might suggest a greater relevance of nitrate 
supplementation when cardio-metabolic function is compromised. Indeed, a similar scenario is 
portrayed by a number of studies reporting no changes by inorganic nitrate on the blood pressure 
of healthy or mildly hypertensive older adults [98,140,142–149]. Moreover, aging might lower 
the ability to bioactivate nitrate, both due to age-related modifications of the oral microbiota 
[150] or changes in gastric pH [151]. One study supports these hypotheses, in which bypassing 
the bioactivation of nitrate by intake of nitrite instead, led to improved indices of balance, 
endurance, and muscle power in older individuals [152].  
However, protective effects of nitrate on age-related functional decline have also been described. 
For instance, when Oliveira and colleagues administered a single dose of beetroot-based 
nutritional gel to older adults with risk factors for cardiovascular disease, they found increased 
oxygen extraction and improved oxygen restoration rate during exercise as well as force recovery 
of handgrip strength [146]. Thus, dietary nitrate seems to ameliorate exercise-recovery time that 
becomes typically slower with aging. In 2019, a large correlation study compared muscle 




higher or lower dietary nitrate intake (yearly estimation, based on individual semi-quantitative 
food frequency questionnaire). As a result, higher nitrate intake was associated with enhanced 
muscle strength and physical function [153]. Yet, another promising study by Coggan et al. 
found increased maximal knee extensor angular velocity and power in a small cohort of healthy 
older men and women (65-79 years old), following acute nitrate intake (BRJ) [154]. Although 
muscle strength is typically considered a good marker for detecting age-related functional 
deficits, muscle speed and muscle power have been indicated as even more accurate predictors 
of age-related functional decline [155,156]. Thus, making the findings by Coggan et al. 
potentially clinically relevant.  
As anticipated, aging is accompanied by an overall decline in metabolic function, leading to 
increased risk for insulin resistance and T2D. In 2011, Sindler et al. showed improved 
endothelial dysfunction and arterial stiffness by inorganic nitrite in old mice (26-28 months old) 
[157]. Expanding on this study, Hezel and colleagues explored the effects of nitrate 
supplementation in age-related hypertension and metabolic dysfunction. In a rat model of natural 
aging, only two weeks with dietary nitrate supplementation improved glucose tolerance, insulin 
resistance as well as insulin release [74].  
To date, human studies assessing the effects of nitrate on age-related metabolic dysfunction are 
somewhat lacking. In one preliminary clinical trial by Gilchrist et al., supplementation with BRJ 
(7.5 mmol nitrate) for two weeks in older, T2D patients did not affect blood pressure nor 
endothelial function. Similarly, insulin sensitivity was not improved by dietary nitrate [98]. Of 
note, patients treated with the antidiabetic drug metformin were not excluded from this study. 
As we now know, both metformin and nitrate are AMPK-activators and this mechanism is likely 
involved in the glucoregulatory effects of nitrate as well. Thus, nitrate treatment might have 
failed showing additional effects to those of metformin on glucose homeostasis. This hypothesis 
is in fact supported by a recent study reporting no synergistic effect of metformin and nitrate on 
metabolic outputs in a mouse model of diet-induced obesity with hypertension [158].  
In summary, more extensive studies are warranted to investigate the potential of dietary nitrate 
in ameliorating metabolic function in the elderly population. These should explore different 













• To assess the effects of dietary inorganic nitrite on longevity and healthspan in the fruit fly. 
• To clarify the importance of the microbiota in bioactivation of nitrate.  
• To study the effects of nitrate on dietary induced metabolic dysfunction and the role of 
commensal bacteria. 




































3 MATERIALS AND METHODS 
3.1 ANIMAL MODELS 
All the in vivo studies performed in vertebrates were approved by the Institutional Animal Care 
and Use Committee in Stockholm and performed in accordance to the guidelines of the 
National Institutes of Health (NIH), with the EU Directive 2010/63/EU for the conduct of 
animal research.  
Study I 
Wildtype Drosophila melanogaster (wDah) fruit flies [159] were reared and maintained on a 
standard sugar-yeast diet (10% SY) prepared accordingly: 10% brewer´s yeast, 5% table sugar, 
1.5% agar [160]. Breeding stocks were housed at constant density. Both breeding stocks and 
experimental flies were housed at constant temperature (25˚C) and humidity (65%), with a 
12h:12h light-dark cycle.   
Study II  
Male C57BL/6J CONV mice were purchased from Janvier Labs (France) at three weeks of age 
and housed in our animal facilities at Karolinska Institutet. GF C57BL/6J male mice were 
obtained from the breeding facility at Astrid Fagraeus Laboratory at Karolinska Institutet 
(Stockholm, Sweden). These mice were housed in gnotobiotic isolators and received sterile 
food and water until the end of the in vivo observational protocol. The germ-free status was 
confirmed on a weekly basis by culturing faecal samples in aerobic and anaerobic conditions, 
at +37 °C. The same bacterial cultures were read for up to two weeks. All animals were 
maintained on a 12 h light/dark cycle, housed at controlled temperature and humidity and given 
free access to food and water.  
From 11 weeks of age, both GF and CONV mice in the treatment groups, were fed a Western 
diet (40 kcal% from fat, 43 kcal% from carbohydrates, 17 kcal% protein, D12079B, Research 
diets Inc., New Brunswick NJ), with the NOS inhibitor Nω-Nitro-L-arginine methyl ester 
hydrochloride (L-NAME; 1 g/L) in drinking (distilled) water. Together with this, the nitrate 
treated animals (n=9) received 10 mM of sodium nitrate (NaNO3) while the placebo group 
(n=6) received 10 mM sodium chloride (NaCl). Control groups of aged-matched GF and 
CONV mice were kept on a regular rodent diet (n=5; R34, 4% kcal from fat, Lantmannen, 
Sweden) and tap water. During this 6-weeks treatment period, body weight, food and water 
consumption were monitored on a weekly basis.  
Study III 
Male C57BL/6J mice were purchased from Janvier Laboratories at 12 weeks of age and housed 
in our animal facilities at Karolinska Institutet, at controlled temperature and humidity, with a 




Lantmannen, Sweden). The high-fat diet (HFD) and HFD + nitrate groups received a high-fat 
diet (60 kcal% fat, 20 kcal% carbohydrate, 20 kcal% protein, D12492, Research Diets Inc., 
New Brunswick, NJ) with the NOS inhibitor L-NAME (1 g/L) in drinking water,  with or 
without inorganic nitrate supplementation (n=6 to 10 per group). 
Body weight, food and water consumption were measured throughout the whole 7-weeks study 
period, after which blood and tissues of interest were collected.  
The GF mice (n=17) in this study, received a double irradiated HFD (40 kcal% fat, 43 kcal% 
carbohydrate, 17 kcal% protein, D12079B, Research Diets Inc., New Brunswick, NJ) and L-
NAME (1 g/L) in drinking water for 7 weeks. The germ-free status was confirmed weekly as 
described in Study II.  
Study IV 
Aged-matched, male GF (n=10) and CONV (n=6) C57BL/6J mice were obtained from the 
breeding at Astrid Fagraeus Laboratory, Karolinska Institutet (Stockholm, Sweden) and housed 
as in Study II. The germ-free status was assessed as described in Study II. All mice in this study 
received sterile food and water. 
From 11 weeks of age, all animals were switched to a double irradiated Western diet containing 
40,7% of total calories from fat; 40,6% from carbohydrate; 18,7% from protein (TD96132; 
Envigo Teklad Diets, Madison, WI) for a period of 16 weeks. Body weight, food and water 
consumption were monitored weekly. A group of age-matched GF and CONV mice fed a 
standard rodent diet (R34: 4% of total calories from fat; 9,5% from carbohydrates; 16,5% from 
protein, Lantmannen, Sweden) is shown for comparison. 
3.2 IN VIVO STUDIES 
Study I 
Lifespan assays were performed using aged-matched fruit flies. Briefly, eggs were 
synchronized and newly emerged flies were allowed a mating period of 48 h. Thereafter, males 
and females were separated under light CO2 anaesthesia and 20 flies were transferred to each 
of 10 experimental vials containing the experimental die (15% SY media prepared as follow: 
15% baker´s yeast, 15% table sugar, 1.5% agar). Such diet was supplemented with 0, 0.1, 1, 10 
or 100 μM inorganic nitrite (NaNO2), added after cooling the media to 65˚C. Dietary restriction 
(DR) media consisted of a 5% SY media, prepared as follow: 5% baker´s yeast, 5% table sugar, 
1.5% agar. Fresh food was provided every second day. At this time, dead flies were counted. 
The first day on a dietary treatment is referred as to the first day of adulthood. 
A fecundity assay was carried out over the first 40 days of the flies´ lifespan as previously 
described [161]. Aged matched female flies were allocated to each of six independent vials (15 
flies/vial) containing the experimental media. Flies were transferred to new food every 3 to 4 
days. At this occasion, unhatched eggs were counted using a microscope. The mean number of 




count. During this assay, flies were fed the same media used for the longevity studies and in 
the presence or absence of inorganic nitrite (0.1 and 1 µM). 
Body weight represents the cumulative weight of 10 female flies. Flies were weighed 
following brief cold anaesthesia and using a precision scale. We report a mean of 7 replicates 
for each experimental group. 
To assess food intake, the food tracer method (FD&C BLUE No. 1, Sigma) was chosen and 
performed as described [161], using aged-matched (14 days old) female flies following a 7 
days period on a 15% SY diet with or without the addition of 1 μM nitrite. Results represent 6 
replicates of 5 flies each.  
Locomotor behaviour was assessed with a rapid iterative negative geotaxis (RING) assay 
[162] in aged-matched female flies, fed a 15% SY diet with or without 1 μM nitrite and kept 
in the same conditions as during the longevity experiments. The RING assay was repeated 7, 
30 and 44 days after allocation of the flies to the experimental media. The six tubes composing 
the RING apparatus contained 15 to 20 flies belonging to randomly assigned treatment groups. 
Flies were transferred into these tubes without anaesthesia. Flies were knocked down to the 
bottom surface of the tubes by firmly tapping the apparatus three times on the surface of the 
bench. A picture was taken after three seconds from the last tap of the apparatus with a digital 
camera located 1 m from the RING apparatus. The procedure was repeated after 1 min recovery 
time. Seven pictures were taken for each set of the experiment. Six independent vials (n = 6) 
were tested per each treatment group. The height climbed by the flies was scored from every 
and each of the 7 pictures taken, in a blinded fashion. Finally, the mean value of the height was 
calculated.  
Study II 
All the in vivo procedures were performed within the same day to avoid contamination of the 
GF mice. The same identical protocol was used for CONV mice. 
Blood pressure recordings were performed by non-invasive tail cuff technique (Kent 
Scientific, Torrington; CT, US). After a 4 h fasting period, fasting glycemia was measured by 
sampling blood from the tail vein and using a portable glucose-meter (FreeStyle Lite; Abbott 
Diabetes Care Inc). Thereafter, an intraperitoneal glucose tolerance test (IP-GTT) was 
performed by injection of a D-glucose solution (2 g/kg of body weight) followed by blood 
glucose measurement (as described above) at 15, 30, 60 and 120 min from administration of 
the glucose dose. Mice were then anaesthetized (light isoflurane-anaesthesia - Forene; Abbott 
Scandinavia AB, Solna, Sweden) in order to assess the body composition by dual-emission x-
ray absorptiometry (DEXA; Lunar PIXImus densitometer; GE Medical-Lunar, Madison, WI, 
USA). Finally, blood and tissues of interested were collected and processed according to 




A separate group of GF male (Fv/BN; n = 7) and CONV (C57BL/6J; n = 14) mice received L-
NAME (1 g/L) in the drinking water for 3-7 days. Following a 5 h fasting period, baseline 
blood pressure was measured over the next hour, as described above. After this procedure, mice 
were orally administered a solution of sodium nitrite (NaNO2, 15 mg/kg of body weight; pH=7) 
or vehicle (control). The maximum volume of liquid administered was set at 1% of the animal´s 
body weight. The nitrite dose was chosen upon consideration of the current literature, 
indicating the effectiveness of such dose in lowering blood pressure in rodents when 
administered orally [163,164]. Blood pressure was measured 90 min following nitrite 
administration.  
Study III 
An intraperitoneal glucose tolerance test (IP-GTT) was performed as described in Study II, 
5 weeks after the start of the dietary intervention. 
An intraperitoneal insulin tolerance test (IP-ITT) was performed 6 weeks following the start 
of the HFD challenge. After measurement of fasting blood glucose, mice were injected with 
insulin (0.75 IU/kg of body weight; Novorapid 100 IU/ml, Novo Nordisk A/S, Bagsvaerd, 
Denmark). Glucose levels were then measured from a blood sample taken from the tail vein at 
15, 30, 60 and 120 min after the insulin injection. For this procedure, animals were not fasted. 
Blood pressure and body composition were assessed after 6 weeks dietary treatment as 
described in Study II. In this study, mice underwent a training period allowing them to adapt 
to the tail cuff equipment. Following this procedure, blood pressure was recorded daily for 
three days. The average of the daily measurements for each mouse was used for statistical 
analyses.  
Study IV 
Fasting glycemia was measured as described in Study II, following 6 h fasting and after 16 
weeks of dietary challenge. 
An oral glucose tolerance test (O-GTT) was performed in this study, by administration of a 
20% D-Glucose solution (in saline) giving a final dose of 2 g/kg of body weight. Glycemia was 
measured as described above at 15, 30, 60 and 120 min after the glucose dose. Immediately 
after, the animals were anaesthetized and body composition was assessed by DEXA, as 
described in Study II. Thereafter, blood and organs of interest were collected, processed 
according to future analyses and snap frozen. Visceral adipose tissue (VAT) and liver were 
weighted fresh while gastrocnemius muscles were dissected and kept in an isolation media on 





3.3 EX-VIVO EVALUATION OF VASCULAR REACTIVITY 
Study II 
Mesenteric arteries were collected immediately after sacrifice and kept in ice-cold Krebs 
solution. Arterial rings (1-2 mm) were obtained from the third branch of the arteries and 
mounted in myograph chambers (model 620 M, Danish Myo Technology, Aarhus, Denmark), 
continuously perfused with oxygenated Krebs solution, as previously described [165]. 
Following stabilization and washout protocols (described in [33]), phenylephrine (PE; 1 
μmol/L) was used to pre-constrict the arterial rings, thus obtaining a basal tone of 
approximately 50% of its diameter.  
To investigate endothelium independent NO vasorelaxation, cumulative doses of sodium 
nitroprusside (SNP; 10−9 to 10−4 mol/L) were added to the chambers at steady-state plateau. 
The vascular responses are presented as % relaxation from the PE pre-constricted vessels. 
EC50 values were calculated using GraphPad Prism v. 8.0. 
3.4 IN VITRO STUDIES 
3.4.1   Cellular studies 
Study III 
Human hepatic cell line HepG2 was used to test the effects of nitrite on metabolically induced 
hepatic steatosis in vitro. DMEM medium (5.5 mM glucose) with 10% fetal bovine serum, 
penicillin and streptomycin (50 mg/L) was used to allow cell growth. Cells were maintained at 
37 °C and 5% CO2. A model of steatosis was created by incubation of the cells (serum-free 
culture medium) with 25 mM glucose, 10 nM insulin and 240 μM FFA (Palmitic and Oleic 
acid mixture 1:1). When indicated, 10 µM sodium nitrite (NaNO2) was added for 24, 48 or 72 
hours. When pharmacological inhibitors were used (Febuxostat 50 nM; Raloxifene 50 nM; 
ODQ 10 μM; Compound C 20 μM), these were added 30 min before the 24 h treatment of the 
cells. Instead, Tempol (100 μM), NOX2/4 inhibitor (GLX481304, 1-50 μM), GLX7013114 
(0.2-2 μM), the slow releasing NO-donor DETA-NONOate (5 μM) and cGMP analogue 8-
pCPT-cGMP (10 μM) were administrated together with the steatosis-inducing mixture. 
Tryphan Blue exclusion assay and PrestoBlue® cell viability assay were used to verify cell 
viability. 
3.4.2   Cellular, biological and biochemical analyses 
Study I 
The gene expression of dTOR and dSir2 was determined in female and male flies kept on a 
15% SY diet with or without the addition of 1 μM nitrite, since 48 h after hatching. After 30 
days, flies were collected under light CO2 anaesthesia and snap frozen. Homogenates for 




(ThermoFisher), according to the manufacturer´s instructions. Expression of the genes of 
interest was performed using SYBR Green (Applied Biosystems) real-time quantitative PCR 
(7500 Fast Real-Time PCR System, Applied Biosystems). Primers used are: dSir2-F: 5′-
ATGGATAAGGTTCGACGCTTCT-3′ dSir2-R: 5′-AGCCGTCAAAACTCAAATCTGG-3′; 
dTOR-F: 3’ – GGCCGTCCAGGTTCAAAAAC - 5’; dTOR-R: 3’ – 
AATCCGGCGATAGTTCCGTC – 5’. Gene expression was calculated using the 2^-ΔΔCt 
method, relative to the level of Alpha-tubulin84B: Alpha-tubulin84B-F 5′-
GCTGTTCCACCCCGAGCAGCTGATC-3′; Alpha-tubulin84B-R: 5′-
GGCGAACTCCAGCTTGGACTTCTTGC-3′. Each sample was assessed in triplicates and 6-
8 biological samples per each treatment group were assayed. 
Mitochondrial function and hydrogen peroxide (H2O2) production were studied in 30 days 
old female flies, raised as above (paragraph 3.2) and fed a 15% SY diet with or without 1 µM 
sodium nitrite (NaNO2). Thorax muscle fibers were obtained following dissection of the fly 
thorax and permeabilized as previously described [166]. Three dissections were kept in 1 ml 
of biopsy preservation solution (BIOPS) and kept on ice until the end of the dissection process. 
Dissected fibers were incubated in 1 ml saponin solution (final concentration 50 μg/ml; Sigma 
S 2149) for 20 minutes (permeabilization) and then transferred to 1 ml incubation media 
(MIR05) for 10 min and let re-equilibrate, on ice and with mild agitation. After the re-
equilibration step, dissections were dried on filter paper and wet weight was assessed with a 
microscale (0.01 mg resolution). 
Mitochondrial oxygen consumption and hydrogen peroxide production were measured 
simultaneously at 37 °C by high-resolution respirometry (Oxygraph-O2K, Oroboros 
Instruments, Innsbruck, Austria). For calibration, horse radish peroxidase (HRP) and Amplex 
UltraRed, 18 µM standard were added to MIR05, in the presence of 10 mM pyruvate and 2 
mM malate. Once reached a stable background Amplex Ultrared autooxidation, permeabilized 
muscle fibers were added to each chamber (containing 2 mL MIR05). Proton leak dependent 
respiration (LEAK) was measured at this stage. 5 mM ADP was added to measure maximal 
complex I dependent (state 3 PM) followed by 20 mM succinate (state 3 PMS) to detect 
complex I+II dependent oxidative phosphorylation capacity (OXPHOS). 0.5 µM rotenone was 
added to measure complex II dependent OXPHOS (state 3 S). Finally, 2.5 µM antimycin was 
used to detect non-mitochondrial oxygen consumption and 0.5 mM TMPD + 2 mM ascorbate 
were added for detection of Complex IV activity. 
H2O2 production was subtracted from the background and respiratory control ratio (RCR) is 
represented by the ratio 3PM/LEAK respiration. Media and solutions were prepared as 
previously described [167]. Data presented were adjusted for autoxidation of TMPD ascorbate 
at the relevant oxygen tension and normalized with each sample´s wet weight. A total of 9 




Total triglycerides (TAG) and glucose levels were assessed in homogenates prepared as 
described [168] and using five 30 days old female flies. Insects were fed a 15% SY diet with 
or without 1 μM nitrite since the first day of adulthood. 
To quantify TAG levels, homogenates were prepared in ice-cold PBST (PBS + 0.05% Tween-
20) using a pellet-pestle, heat-treated and incubated with either PBST for free glycerol 
measurement or triglyceride reagent to digest TAG and detect the glycerol backbone. 
Absorbance was measured at 540 nm using a spectrophotometer. Finally, TAG concentration 
was calculated: [free glycerol] - [total glycerol]. Each sample´s TAG content was determined 
based on a triolein-equivalent standard curve. 
Total glucose was measured with a Hexokinase (HK) assay. Flies were fasted for 6 h before 
being homogenized in ice-cold PBS as above. The obtained samples were heat-treated and 100 
μl of HK reagent (Sigma; GAHK20) were added to 30 μl of sample. Absorbance was measured 
at 340 nm and free glucose concentration determined by comparison with a glucose standard 
curve.  
For both TAG and glucose assays, samples were plated in duplicates on a 96 well plate. The 
final concentrations presented here have been normalized to the total amount of protein/sample 
which was quantified by Bradford assay. 
Study III 
Tissue NOX activity was detected by a lucigenin-dependent chemiluminescence assay 
(AutoLumat LB953 Multi-Tube Luminometer; Berthold Technologies, Bad Wildbad, 
Germany). Results were normalized to protein levels.  
Superoxide production in HepG2 cells was detected by injecting the substrate NADPH (100 
μmol/L) in the presence of dark-adapted lucigenin (5 μmol/L) to then measure the 
chemiluminescence signal. NOX-derived superoxide and hydrogen peroxide in liver tissue 
was performed by measuring Amplex Red-derived fluorescence in tissue homogenates. 
Fluorescence was measured for 120 min (excitation 530 nm; fluorescence detection 590 nm). 
The signal was normalized according to the protein concentration and presented as % changes 
of the respective control animals. 
NADPH-derived ROS detected by lucigenin-chemiluminescence technique in HepG2 cells 
was validated using superoxide dismutase (SOD) and catalase to show that the latter did not 
influence the signal while SOD almost completely abolished it, thus demonstrating that this 
assay is predominantly assessing superoxide and not hydrogen peroxide production. 
Superoxide and NO species were detected by Electron Paramagnetic Resonance (EPR). 
Neutral lipid accumulation in cells and liver was detected by Oil Red O (ORO) staining. 
Fresh liver tissue was embedded in OCT cryomount embedding medium (Histolab Products 
AB, Sweden) and snap frozen. The staining procedure was performed on frozen sections (10 




and let air dry for a few minutes. Absolute propylene glycol was added for 5 minutes before a 
10 min incubation with pre-warmed Oil Red O solution (0.5% in absolute propylene glycol) 
and followed by differentiation in 85% propylene glycol for 3 min. After rinsing, Mayer´s 
Hematoxylin was added on each section for 30 sec. Sections were finally washed and mounted 
with glycergel mounting medium before acquisition of images. Lipid deposition was quantified 
from the images in a blinded fashion (ImageJ software).  
Hepatic triglyceride content was assessed by Triglyceride Assay Kit (Abcam, ab65336). 
according to the manufacturer´s instructions.  
mRNA expression levels of the genes of interest were determined by real-time PCR in liver 
homogenates, using Power SYBR Green Master mix (Thermo Fisher Scientific).  RNA 
extraction was performed with a RNeasy Mini Kit (Qiagen, Sollentuna, Sweden). Relative 
changes in mRNA expression were calculated using the ΔΔCt-method and normalizing the 
results to the housekeeping gene β-actin. Primers sequences are found in Study III 
supplementary information. 
Western blot analyses were performed to detect proteins of interest in HepG2 cells and liver 
tissue. To do so, cells were lysate in the presence of protease inhibitor cocktail and 
Serine/Threonine Protein Phosphatases or Tyrosine Protein Phosphatases inhibitors. Liver 
homogenates were obtained using a bullet blender device and zirconium oxide beads (0.5 mm). 
Polyvinylidene difluoride membranes were washed with Western Blot Stripping Buffer before 
incubation with the anti-phospho protein primary antibody, to eventually detect the 
phosphorylated protein. Vinculin was used as loading control. For details see Study III 
supplementary information. 
Study IV  
Hepatic triglycerides were quantified using a Triglyceride Colorimetric Assay kit (Cayman 
Chemical Company). 
Lipid accumulation in hepatic tissue was assessed by Oil Red O staining of 10 µm-thick liver 
sections, as described in Study III.   
CPT1 activity was studied in isolated mitochondria from gastrocnemius muscles. These were 
kept in isolation media (sucrose 250mM, HEPES 10mM, EGTA 1mM, BSA 1g/L, pH 7,4) on 
ice at 4˚C over-night. On the following day, samples were weighted and homogenized using a 
potter elvehjem homogenizer on ice in presence of proteinase (0.2 mg/ml). Homogenates were 
resuspended in 3 ml isolation medium and centrifuged (700 × g for 10 min). The resulting 
supernatant was further centrifuged (10,000 × g for 10 min). Pellets were washed to remove 
the buffy coat and recentrifuged (7000 × g for 5 min). Finally, they were washed and diluted 
(0.3 μl mg-1 initial tissue weight) in preservation medium (EGTA, 0.5 mM; MgCl2, 3 mM; K-




histidine, 20 mM; vitamin E succinate, 20 mM; glutathione, 3 μM; leupeptin, 1 μM; glutamate, 
2 μM; malate, 2 μM; BSA 1 g/l and Mg-ATP 2mM) and kept on ice until analysed. 
CPT1 activity was studied with high resolution respirometry (O2-K, Oroboros, Austria) and 
mitochondrial respiration measured in the presence of palmitoyl-CoA (40μM), I’carnitine 
(0.5mM), malate (0.1 mM) and ADP (2.5mM). DatLab7 (Oroboros) was used for data 
acquisition. Respiration was normalized to the mitochondrial protein. 
3.4.3   Nitrate, nitrite and NO detection 
Study I 
NO generated by Drosophila microbiota was assessed in bacterial cultures obtained by 
homogenizing fruit flies in Mueller Hinton bacterial culture media, using a sterile pestle. 
Bacteria were grown anaerobically overnight, in an air-tight chamber together with an 
anaerobic pouch (AnaeroGen compact AN0035, Oxoid Basingstoke, England) at 37˚C and 
with mild shaking. NO was detected in air samples obtained from three gas tight infusion bags, 
made of a multilayer double wound film (M312), after filling them with nitrogen gas (500 ml) 
and the bacterial suspension + 100 μl of a sterile sodium nitrite solution (NaNO2; 1 mM final 
concentration) or sterile Mueller Hinton (control). NO gas concentrations were measured with 
a rapid response chemiluminescence system (Aerocrine AB, Stockholm, Sweden). Air was 
sampled every 2, 4, 6 and 8 hours. Bags were otherwise kept at 37˚C, with continuous mild 
shaking. This procedure was repeated in two independent experiments. The instrument’s 
detection limit for NO was 1 ppb. At the end of the experiment, the pH of each bag´s content 
was assessed with a tritest pH revealing paper. 
Nitrite consumption was determined in flies´ homogenates, prepared as described above. 
Penicillin-Streptomycin (10,000 Units/ml Penicillin, 1000 μg/mL Streptomycin; Gibco) was 
added (100 μg/ml final concentration) to two aliquots and the resulting samples were incubated 
for 1 h in anaerobic conditions at 37˚C. At this stage, two new aliquots were sampled from the 
whole homogenate and nitrite (1 mM) was added to half of all aliquots. Samples were 
maintained at 37˚C in anaerobic conditions for the entire duration of the experiment. 
Immediately after nitrite addition (time 0) and every 2 h up to 8 and 24 h, 50 µl of sample were 
extracted. An equal volume of methanol (Methanol for HPLC, ≥ 99,9%; Sigma-Aldrich) was 
added and samples were stored at -20 ˚C until analysis. For nitrite detection, samples were 
centrifuged (10000 g x 10 min at 4 ˚C) and injected into a HPLC system (ENO-20) with a 
Hamilton syringe. Nitrate and nitrite were separated by reverse phase/ion exchange 
chromatography followed by nitrate reduction to nitrite by cadmium and reduced copper. Then, 
nitrite was derivatized with Greiss reagent to form diazo compounds which were detected at 
540 nm. 
DAF-FM DA was detected in whole fly homogenates prepared from 5 untreated female flies 
for each sample (n=6). Homogenates were spun-centrifuged at 4˚C, to precipitate any debris 




with or without 1 μM sodium nitrite (NaNO2) and the fluorescent probe DAF-FM DA (5 µM). 
Fluorescence was measured with a microplate reader (SpectraMax iD3, Molecular Devices) 
every 5 min for 1 h at 28 °C, with excitation 465 nm and emission 515 nm. The average 
fluorescence values for each duplicate were normalized to the protein content of each sample, 
obtained by Bradford assay. 
Studies II and III 
Plasma and tissue nitrate and nitrite were analysed by HPLC (ENO-20) as described 
previously [87,169] and in Study I. In these studies, 10 µl of plasma were used. 
3.5 STATISTICAL ANALYSES 
In all studies data are presented as mean ± SEM, unless otherwise stated. A t-test or Mann-
Whitney test were used for comparisons between two groups and one-way or two-way 
ANOVA for comparisons among two or more groups. The appropriate post-tests were used for 
multiple comparisons.  
In Study I, a log-rank (Mantel-Cox) test was used for comparisons between two survival 
curves.  
In Study II, delta mean arterial blood pressure (MAP) was calculated by subtraction of MAP 
absolute values (mmHg) at baseline and after oral administration of vehicle or nitrite. 
Comparison of control and nitrite treated animals, within each group of animals (CONV and 
GF) was carried out using a parametric unpaired t-test. 
A p-value of less than 0.05 was considered statistically significant and statistical analyses were 
performed using GraphPad Prism, version 7 (Study III) or version 8 (GraphPad Software).  
4 RESULTS AND DISCUSSION 
4.1 STUDY I 
Dietary nitrite extends lifespan and prevents age-related locomotor decline in 
the fruit fly 
 Inorganic dietary nitrite extends lifespan in the fruit fly 
Based on existing evidence on the salutary cardiovascular, metabolic and antioxidant effects of 
dietary nitrate, we addressed the question whether an attempt to stimulate NO production via 
the diet, would preserve health during natural aging, thus extending longevity.  
To do so, we based our investigations on the short-lived model organism Drosophila 
melanogaster. Longevity studies were performed in both female and male fruit flies (Figure 
2E; F), fed a 15% sugar-yeast (SY) media with the addition of 0, 0.1, 1, 10 and 100 µM sodium 
nitrite (NaNO2). In our survival studies, the lowest nitrite concentrations, 0.1 and 1 µM, 




2A; B). At higher nitrite concentrations (10 and 100 µM), median lifespan extension (by 11 
and 6%, respectively) was not reflected by a statistically significant increase in cumulative 
survival (Figure 2C; D).  Nitrite did not affect lifespan in male flies (Figure 2F). 
 
 
Figure 2. Survival curves of female flies fed a 15% SY media with 0.1 µM (A; n=199; χ2=5.268; p=0.022); 1 µM 
(B; n=197; χ2=5.326; p=0.021); 10 µM (C; n=197; ns) and 100 µM inorganic nitrite (D; n=202; ns), were 
compared to untreated flies (control; n=207). Log-rank test was used for comparison between two curves. Reported 
p-values indicate comparisons nitrite vs control. Cumulative survival of female (E) and male (F) flies. 
 
To our knowledge, a nitrate-nitrite-NO pathway has never been described in fruit flies. As 
nitrate would need bacterial activation in order to form NO [3,19,170], we decided to bypass 




The fact that only the lowest concentrations of dietary nitrite significantly extended the fly 
lifespan might seem surprising. Nevertheless, a U-shaped response to nitrite has been reported 
previously in animal models of hepatic and myocardial ischemia-reperfusion injury, whereby 
nitrite was effective at low but not at high concentrations [171].  
In our study, nitrite extended lifespan in female but not in male flies. Notably, other dietary 
interventions (i.e. dietary restriction) [172,173] and molecules (resveratrol, rapamycin) that 
extend longevity are often more effective in females [174,175]. The reasons for sex differences 
in longevity are so far speculative, both in the case of intervention-based manipulations of the 
lifespan but also as a result of physiologic aging [176]. Two major driving factors have been 
proposed: sex differences in energy demand and allocation and sex differences in the 
insulin/IGF-1 signaling [172]. In Drosophila, energy expenditure and intake seem to differ 
between males and females [177] and also in mammals, studies have indicated higher energy 
demand in females [178,179].  It is possible that females across species generally require higher 
energy intake for reproduction. This might even be amplified in flies. In support of this idea, 
Drosophila female´s lifespan is shortened by mating [180–182].  
Alternatively, the described sex dimorphism in the insulin/IGF-1 pathway could explain sex 
differences in longevity. This hypothesis arouse from evidence that downregulation of this 
pathway leads to greater lifespan extension in females than in males [183–185].  
Other explanations have been suggested, based on important physiologic differences between 
sexes. For instance, the antioxidant and anti-inflammatory properties of oestrogens have been 
proposed as protective of the female lifespan in mammals [176] and resveratrol, a 
phytoestrogen, shows greater pro-longevity effects in females [186].  
Although median lifespan was significantly increased by 0.1 and 1 µM nitrite, maximum 
lifespan was left unaffected. One possible explanation is that the extension in median lifespan 
produced by dietary nitrite might be secondary to improved healthspan (defined as the length 
of life free from disease). Demographic studies in Drosophila have delineated two possible 
reasons for lifespan extension: either decreased rate of aging (i.e. cold exposure in flies) [187] 
or reduced likelihood of death resulting from accumulation of age-related damage [188].  The 
latter seems to be the case of dietary restriction (DR) [187] which, similarly to nitrite, affects 
median lifespan more than maximum lifespan [172].    
To verify whether the effects of nitrite would be secondary to a DR effect (i.e.  by alteration of 
food palatability leading to reduced food intake) we measured the body weight as well as food 
intake and egg laying in female flies. Body weight and food consumption were not altered by 
nitrite, confirming a “true” nitrite-driven effect (Figure 3B; C). Also, female fecundity was 





Figure 3. Fecundity assay (A), body weight (B) and food intake (C) of female flies fed a 15% SY diet with or 
without (control) nitrite supplementation (0.1 and 1 µM). Data are shown as mean ± SEM.  p-values were 
determined with a two-way ANOVA for egg-laying (n=6 per group). Body weight (n= 8-7 per group) was analysed 
with one-way ANOVA to compare treatment groups within the same time-point. Food intake (n=6 per group) was 
analysed by t-test. 
Although increased longevity is often paired with decreased fecundity [189], studies are 
indicating that this dogma of aging biology might need reconsideration. For instance, both 
resveratrol and a selective TOR inhibitor could increase the fly lifespan without affecting 
fecundity  [190–192].  
 NO generation from nitrite in Drosophila 
One important question to address is whether fruit flies can reduce nitrite to biologically active 
NO. Knowing that anaerobic gut bacteria, at least in mammals, are able to carry out such 
reduction reaction [193], we produced anaerobic bacterial cultures from whole fly 
homogenates to then measure NO gas formation from inorganic nitrite. Following inoculation 
with 1 mM nitrite, anaerobic fly bacteria immediately produced large amounts of NO gas 
(Figure 4A). In the same experimental setting, we strengthen this evidence by measuring also 
bacterial nitrite consumption instead of NO production exclusively. As expected, nitrite 
concentrations declined steeply 6 hours after nitrite addition to the bacterial cultures, becoming 
completely undetectable after 8 hours. On the contrary, when bacteria were eliminated using 
an antibiotic mix, nitrite concentrations remained stable over 24 hours (Figure 4B). 
Furthermore, at the end of these experiments, we noted that bacterial cultures had become 
acidic (pH 4-5) as compared to their control (pH 7-8). Although this evidence speaks in favour 
of a predominant role of bacteria in “bioactivating” nitrite in flies, we wanted to test the 
hypothesis of a potential non-bacterial enzymatic contribution. Therefore, we measured NO-
related species in whole fly homogenates in the presence and absence of nitrite (1 µM) and in 
aerobic conditions. Although the assay we used does not directly detect NO, DAF-FM DA 
remains a sensitive fluorescent probe of common use for assessing NO formation in biologic 
samples. In this experiment, nitrite addition increased the fluorescent signal in whole fly 
homogenates (Figure 4C). This experiment confirms that fruit flies are able of NO generation 





Figure 4. NO gas generation (ppb) by anaerobic bacterial cultures from flies after inoculation with 1 mM NaNO2 
(n=3 in two independent experiments; A). Nitrite consumption by Drosophila anaerobic bacteria, in the absence 
(control) or presence of 1 mM nitrite and with or without antibiotics (Penicillin-Streptomycin, 100 mg/ml; B). 
Detection by DAF-FM DA of NO-related species derived from 1 µM nitrite in whole fly homogenates during 
aerobic conditions (C; n=6). Data are shown as mean ± SEM. Statistical significance was determined by two-way 
ANOVA with Tukey correction for multiple comparisons (A; B) and t-test (C). 
Overall, these experiments indicate that a nitrite-NO pathway exists and is functioning in fruit 
flies. Based on this evidence, it is tempting to speculate that a backup system ensuring NO 
homeostasis is of enough physiologic importance to be selected by evolution and kept intact 
across species and time. It is fascinating also to note some similarities with the better 
characterized mammalian nitrate-nitrite-NO pathway [19]. The most striking is probably the 
involvement of bacteria in NO formation. An involvement that, according to the evidence 
presented in Figure 4B, might be nearly as important in Drosophila as in mammals (Study II) 
[170]. Expanding on this, the observation that bacterial cultures from flies become acidic while 
generating NO from nitrite, might suggest a strong contribution by i.e. lactic acid producing 
bacteria. One example is Lactobacillus, which might induce non-enzymatic and pH-driven 
reduction of nitrite by generating lactic acid. The excellent nitrite-reducing abilities of this 
bacterial genus have been reported in mammals [193] and we could indeed isolate 
Lactobacillus from Drosophila homogenates. It is also true that enzymatic reduction of 
nitrate/nitrite to NO is present in mammals [50]. Similarly, an additional contribution from the 
host to NO generation is suggested by this study in the fruit fly.  
 Dietary inorganic nitrite prevents age-related locomotor decline in female flies 
When exploring interventions that positively affect the aging process, studying the healthspan 
may be of even greater relevance than investigating an organism´s lifespan. Therefore, we 
wanted to find out whether a longer life would be coupled to improved or delayed age-related 
functional decline upon nitrite consumption. Locomotor ability progressively deteriorates with 
aging in several species. In Drosophila, locomotion is a behaviour termed “negative geotaxis”: 
an escape instinct whereby insects ascend the wall of a tube whenever they are knocked down 
to the bottom [162,194]. We performed a rapid iterative negative geotaxis (RING) assay to 
assess the locomotor behaviour of female flies from a younger age (7 days old) and during 
aging (30 and 44 days old). According to our findings, life-long nitrite supplementation (1 µM) 













































































preserves the locomotor ability of aged (30 days old) female flies, as compared to untreated 
controls (Figure 5). This effect seems to persist in older flies (44 days), although not reaching 
statistical significance.  
 
Figure 5. Height climbed by female flies subjected to a RING assay while fed a 15% SY media with or without 1 
µM sodium nitrite (NaNO2). Data are shown as mean ± SEM of two independent experiments. (n=6/group for 
each independent experiment). Mann-Whitney test was used for comparison within each timepoint and two-way 
ANOVA with Sidak correction for comparisons among different timepoints.  
Other pro-longevity molecules such as resveratrol [195–198], are known to improve 
locomotion in flies and dietary nitrate itself is proving a promising intervention protecting 
physical function in older adults (as discussed in Chapter 1.7).  
These results suggest that inorganic dietary nitrite, by promoting healthy aging, leads to life 
extension in the fly. 
Improved mitochondrial efficiency is suggested to be involved in the exercise-enhancing 
effects of dietary nitrate in humans [13]. For this reason, we investigated mitochondrial 
function in isolated thorax muscle fibers of aged female flies supplemented with dietary nitrite 
(1 µM). As we could not detect any differences between the two groups, we anticipate that 
modulation of mitochondrial function might not explain the protective effect of nitrite on 
locomotor decline in the aged flies. One possible explanation could be species-specificity of 
the interaction between NO and the mitochondria. In support of this hypothesis, a recent study 
showed increases in voluntary running by nitrate in mice, but unlike in humans [13], the P/O 
ratio was decreased by nitrate [199]. Alternatively, it might be possible that the actions of 
nitrate and nitrite differ on mitochondrial function. As an example, in an in vitro setting, nitrite 
was previously reported to have no effect on mitochondrial LEAK or state 4 respiration from 




 Dietary inorganic nitrite modulates metabolic pathways in aged female flies 
Our findings showing positive modulation of both the lifespan and healthspan by dietary nitrite, 
triggered our interest in exploring the potential molecular reasons behind such effects. 
Nutrient sensing pathways are known to become dysregulated with aging as well as in 
metabolic disorders [200]. The insulin/IGF-1 pathway is an important modulator of the aging 
process and calorie restriction is known to extend longevity by suppression of this pathway. 
Other important nutrient sensors are AMPK and its downstream target TOR, as well as sirtuins. 
Both AMPK and sirtuins are downregulated by aging and their activation has been linked to 
increased longevity. Importantly, interventions modulating these pathways, do not exclusively 
extend lifespan but they also positively impact on metabolism by improving insulin sensitivity, 
glucose tolerance, physical performance and counteracting lipid accumulation as well as 
oxidative stress [201–203]. Most of these features have been observed following dietary nitrate 
supplementation [22,23], which is also known to activate AMPK [23].  
We therefore assessed the mRNA levels of two important regulators of metabolism and aging, 
dTOR and dSir2 (homolog of the mammalian sirtuin SIRT1).  
In line with our longevity studies, life-long nitrite supplementation (1 µM) reduced dTOR 
mRNA levels in aged female flies (Figure 6A; p=0.033). Downregulation of dTOR is known 
to mediate the longevity effect of DR and rapamycin [203]. Moreover, activation of AMPK 
also leads to TOR suppression and some AMPK-activators have been reported to extend 
lifespan [204,205]. One of these is metformin [204], which shares features with nitrate 
including the ability to activate AMPK [158].  
In the same population of female flies, dietary nitrite led to a significant, although mild, 
upregulation of dSir2 mRNA levels (Figure 6B; p=0.036). In mammals, SIRT1 activators have 
gained much attention owing for their DR-mimetic effects on metabolism and aging [206]. 
Resveratrol is likely the most studied sirtuin activator of dietary origin. This polyphenol is 
known for its antioxidant properties, it has also been shown to protect mice from obesity, 
improve mitochondrial function, physical activity and extend lifespan [202].  
Consistent with a sex-dependent effect of nitrite on the fly longevity, we did not detect 
significant changes in either dTOR or dSir2 in aged male flies (Figure 6C; D). 
Supportive of a role for these nutrient sensing pathways in the modulation of the fly lifespan 
by nitrite, supplementation with this anion (1 µM) lowered total triglycerides and glucose levels 





Figure 6. mRNA levels of dTOR (A; n=8) and dSir2 (B; n=6) in 30 days old female flies and male flies (C; D 
respectively; n=6). Relative gene expression was calculated using the 2^-ΔΔCt method. Data are shown as mean ± 
SEM of each biologic replicate. Unpaired t-test was used to determine statistical significance (*p < 0.05). 
Although indicative of nutrient sensing modulation by nitrite, our findings do not provide a 
causal link between the observed changes in dTOR and dSir2 mRNA levels and increased 
longevity. Future studies should address this matter, for instance by testing the effects of dietary 
nitrite in dTOR and dSir2 mutant flies supplemented with nitrite. Similarly, whether nitrite acts 
as a DR mimetic would need further clarification by studying the lifespan of fruit flies subjected 
to DR and nitrite supplementation simultaneously.  
Finally, this study highlights the potential of boosting NO production via the diet as a mean to 
protect health during the aging process. Thus, it should be assessed if the pro-longevity effects 
reported here could be reproduced by dietary nitrate in mammals.  
4.2 STUDY II 
The obligatory role of host microbiota in bioactivation of dietary nitrate 
 Effects of a Western diet and dietary nitrate on the body weight of germ-free and 
conventional mice  
The pivotal role of our bacteria in bioactivating dietary nitrate, ensuring its beneficial biologic 




in Study I we revealed that even in the fruit fly, a surprisingly important relationship between 
bacteria and their host drives NO generation from dietary nitrite. 
In this study, we used GF mice to clarify the importance of host microbiota in the 
cardiovascular and metabolic effects of dietary nitrate-derived NO bioactivity. To do so, we 
induced metabolic dysfunction and hypertension in both GF and CONV mice by feeding them 
a combination of a Western diet and the NOS inhibitor L-NAME (1 g/L in drinking water) for 
6 weeks. We supplemented half of these mice with sodium nitrate (NaNO3, 10 mM) or placebo 
(NaCl, 10 mM) in drinking water and compared them to a group of untreated mice (control). 
At the end of the dietary challenge, both GF and CONV mice had developed an obese 
phenotype, with increased fat mass (Figure 7C; D) and decreased lean mass (Figure 7E; F). 
Nonetheless, CONV mice in the nitrate group gained weight to a lesser extent than the placebo 
group, as compared to untreated CONV mice (Figure 7A). Accordingly, the increase in fat 
mass was milder in CONV mice supplemented with nitrate than in the CONV placebo group 
(p=0.056; Figure 7C). No such trend was observed in GF mice, whereby a Western diet 
significantly increased body weight (Figure 7B) and fat mass (Figure 7D), irrespective of the 






Figure 7. Body weight (A; B), fat (C; D) and lean mass (E; F) of CONV and GF mice following 6 weeks on a 
standard rodent diet (control) or Western diet (WD) + L-NAME (1 g/L), with either 10 mM NaCl or 10 mM 
NaNO3 in the drinking water. Data are shown as mean ± SEM. One-way ANOVA with Tukey post-test was used 
for multiple comparisons. n numbers aa indicated within the bar chart. 
The salutary effects of dietary nitrate have been described in several animal models in respect 
to metabolic function and, to a greater extent, cardiovascular function [23,27]. However, while 
the anti-hypertensive and anti-diabetic actions of inorganic nitrate have been predominantly 
consistent among studies, decreased body weight or prevention of weight gain by dietary nitrate 
have been indicated in some reports [80,87,93,207,208] but not in others [158,169,209]. Thus, 
the potential benefits of inorganic nitrate as an anti-obesity agent need further clarification 
[210]. Nonetheless, based on the data presented above, a trend towards a protective effect of 
nitrate on diet-induced weight gain in CONV mice is totally lacking in GF mice. This indicates 




 The antidiabetic effects of dietary nitrate are dependent on the microbiota 
In CONV mice but not in GF mice, dietary nitrate effectively prevents the deleterious effects 
on glucose tolerance caused by a protracted Western diet consumption (Figure 8).  
Accordingly, Cordero et al. (Study III) reported no effects of nitrate supplementation on diet-
induced hepatic steatosis in GF mice. On the contrary, such complication of T2D was 
effectively prevented by nitrate in CONV mice [209]. Together, these findings provide new 
and strong evidence on the obligatory role of the host microbiota in the antidiabetic effects of 
inorganic nitrate. 
 
Figure 8. Glucose tolerance tests in CONV and GF mice after 6 weeks on a standard rodent diet (control; n=5) or 
a Western diet (WD) + L-NAME (1 g/L) with either 10 mM NaCl (n=6) or 10 mM NaNO3 (n=9) in the drinking 
water. Data are shown as mean ± SEM Two-way ANOVA with Tukey post-test was used for multiple 
comparisons. * placebo vs control; # nitrate vs control; ¤ placebo vs nitrate. 
 The cardiovascular effects of dietary nitrate are dependent on the microbiota 
Six weeks on a Western diet and L-NAME produced an increase in mean arterial blood pressure 
(MAP) in both GF and CONV mice, as compared to their respective control groups. However, 
CONV mice supplemented with dietary nitrate were protected from such increase. This effect 







Figure 9. Mean arterial blood pressure (MAP) of CONV and GF mice after 6 weeks on a standard rodent diet 
(control) or a Western diet (WD) + L-NAME (1 g/L) with either 10 mM NaCl or 10 mM NaNO3 in the drinking 
water. Data are shown as mean ± SEM One-way ANOVA with Tukey post-test was used for multiple comparisons. 
The nitrate dose used in this study (10 mM) was previously shown to elicit clear blood pressure 
and gluco-regulatory effects when administered orally in rodents [30]. This dose is higher 
compared to what is normally used in human studies but takes into account the demonstrated 
lower ability of rodents to concentrate nitrate in salivary glands, as compared to humans [211]. 
Nevertheless, we cannot exclude that a higher dose would trigger an anti-hypertensive response 
even in GF mice. To this regard, an earlier study by Jansson et al. [50] reported lowered blood 
pressure by intravenously administered nitrate in CONV anesthetized rats. This led the authors 
to anticipate a mammalian enzymatic contribution to the bioactivation of nitrate and its effects 
on blood pressure. However, in these animals the swallowing reflex was likely inhibited by the 
anaesthesia, thus disrupting the enterosalivary nitrate circulation. Moreover, according to 
recent studies [212], it is possible that gut bacteria instead of oral bacteria were responsible for 
the nitrate reduction to nitrite in the Jansson study. In fact, bacterial reduction of circulating 
nitrate can also take place in the small intestine, leading to increased nitrite levels in the portal 
circulation [212]. 
Importantly, our findings do not exclude that mammalian enzymes, such as XOR as indicated 
by Jansson et al. [50], might play an important role in the nitrate-nitrite-NO pathway. This 
could be especially true under certain conditions such as hypoxia, when NO formation from 
nitrate/nitrite is enhanced [171,213] or within specific tissues where the high expression of 
XOR prompts mammalian nitrate bioactivation [114]. 
 The NO signaling downstream of nitrate is intact and functioning in germ-free 
mice 
To validate the idea that GF mice do respond to an exogenous stimulation of NO production, 
we performed an acute in vivo experiment whereby GF and CONV mice were given a high 




and CONV mice both showed decreased MAP (Figure 10). Finally, to further strengthen this 
evidence, additional ex vivo evaluation of vessel response showed equal vasorelaxation of GF 
and CONV mesenteric arteries to the NO donor sodium nitroprusside (SNP).  
 
Figure 10. Changes in mean arterial pressure (Delta MAP) of CONV and GF mice after oral administration of 
either vehicle (control) or sodium nitrite (NaNO2; 15 mg/kg of body weight). Data are shown as mean ± SEM.  
Statistical significance was assessed by unpaired t-test.  
Together, these experiments confirm that in GF mice, the ability to reduce nitrite to NO as well 
as the physiologic response to NO are both intact. Thus, a lack of a biological effect in response 
to nitrate supplementation in the GF mouse is attributed to the complete absence of bacteria 
and their ability to generate of nitrite.  
4.3 STUDY III 
AMP-activated protein kinase activation and NADPH oxidase inhibition by 
inorganic nitrate and nitrite prevent liver steatosis 
 Dietary nitrate protects against hepatic steatosis: the indispensable role of bacteria 
The aim of this study was to broaden our knowledge on the protective effects of dietary nitrate 
in T2D and hepatic steatosis, when these are secondary to obesity. Similar to Study II, a mouse 
model of metabolic disease and hypertension was created by high fat (HF) diet feeding coupled 
with NOS inhibition (L-NAME, 1 g/L in drinking water) for 7 weeks. In line with previous 
reports [23,27], supplementation with inorganic nitrate (1.0 mmol kg of body weight per day) 
prevented a L-NAME-driven elevation in blood pressure as well as glucose intolerance and 
endothelial dysfunction.  
Mice fed a HF diet showed hepatic lipid accumulation, which was prevented by dietary nitrate 
(Figure 11A). However, when the same in vivo model was recreated in the GF mouse, these 
protective effects of dietary nitrate could not be reproduced (Figure 11B). This evidence, 




of the microbiota in bioactivation of dietary nitrate, which is indispensable for its metabolic 
effects.   
To better explore the mechanisms behind a NO-driven protection against hepatic steatosis, we 
created an in vitro model of the disease. Human hepatocyte cell line HepG2 were incubated for 
24h with glucose, insulin and a free fatty acids (FFA) mixture. Staining of these cells with Oil 
Red O, confirmed the accumulation of lipids. In line with the in vivo study, incubation of the 
cells with nitrite prevented such effect. Importantly, these results were obtained using sub-
micromolar concentrations of nitrite, which are close to the physiologic levels in tissues and 
easily achievable via the diet [19,214]. 
 
Figure 11. Oil-Red O staining of hepatic tissue of CONV (A) and GF mice (B) after 7 weeks on a standard rodent 
diet (control) or a HF diet with L-NAME (1 g/L) and either sodium nitrate (NaNO3; 1.0 mmol·kg−1·d−1) or placebo 
(NaCl) in drinking water (scale bars: 1 μm). Quantification of neutral lipids was performed using ImageJ software. 
Data are presented as mean ± SEM of n = 5-9 per group. Statistical significance was determined by Kruskal–
Wallis test and Dunn’s test. Modified from 10.1073/pnas.1809406115. 
 Nitrate and nitrite activate AMPK and reduce NOX activity   
AMPK is a master regulator of glucose and lipid metabolism, playing a key role in hepatic lipid 
accumulation [215] and excess of nutrients is known to suppress its activation [102,103,216]. 
Accordingly, mice fed a HF diet displayed decreased levels of p-AMPK (active form) as 
compared to untreated controls. When the HF diet was paired with nitrate supplementation, 
such effect was prevented (Figure 12A). These same results were reproduced in the in vitro 
model of hepatic steatosis described above. 
The PI3/Akt signaling pathway is triggered by insulin and plays a crucial role in T2D and 
obesity [217]. According to our results both in liver tissue and cells, Akt does not seem to be 




previous reports [218], we indicate that these are mediated by insulin-independent activation 
of AMPK. 
 
Figure 12. Protein expression of AMPK (A) and Akt (B) in hepatic tissue of mice after 7 weeks on a standard 
rodent diet (control) or a HF diet with L-NAME (1 g/L) and either sodium nitrate (NaNO3; 1.0 mmol·kg−1·d−1) or 
placebo (NaCl) in drinking water. Data are presented the mean ± SEM of n= 9-10 per group. Statistical significance 
was determined by Kruskal–Wallis test and Dunn’s test. Modified from 10.1073/pnas.1809406115. 
Dietary nitrate supplementation is known to reduce NOX activity and the resulting antioxidant 
effect has been previously associated with modulation of metabolic function by nitrate 
[22,108]. In our in vivo model of metabolic disease, chronic HF feeding increased hepatic NOX 
activity and NOX-driven superoxide production. A positive correlation between NOX activity 
and lipid accumulation in the liver was also noted. On the other hand, when mice were 
supplemented with nitrate, the increase in hepatic NOX activity was prevented.  
Similarly, in the in vitro model of hepatic steatosis, incubation with the steatotic mixture 
elevated NOX-derived superoxide production and this effect was absent when cells were 
exposed to nitrite. Confirming the role of NOX-derived superoxide generation in lipid 
accumulation, cells were incubated with either the superoxide scavenger tempol or with two 
different NOX inhibitors. In both cases lipid accumulation was prevented.  
 NO is responsible for the anti-steatotic effects of nitrate and nitrite 
Nitrite exerts its biologic effects following a bioactivation process, not exclusively to form NO 
but also other bioactive nitrogen oxides such as S-nitrosothiols and the nitrogen dioxide radical 
[219]. Therefore, we sought to verify whether the effects seen in vitro following exposure to 
nitrite would be mediated by NO. To do so, we tested if increased or decreased NO signaling 
would modulate AMPK and NOX activity in accordance with the previously obtained results. 
In steatotic HepG2 cells incubated with the NO donor DETA-NONOate or the cGMP activator 
8p-CPT-cGMP, we obtained similar effects on AMPK as with nitrite in vitro. This indicates 
that the biologically active molecule responsible for modulation of AMPK signalling, and 




both DETA-NONOate and 8-pCPT-cGMP and abolished by the sGC inhibitor ODQ in the 
presence of nitrite.  
XOR and aldehyde oxidase (AO) are two molybdopterin-containing enzymes known to 
catalyse the reduction of nitrite to NO [220]. To investigate their involvement in nitrite 
reduction to NO in the in vitro setting, the XOR inhibitor febuxostat and the AO inhibitor 
raloxifene were used. XOR inhibition blunted the positive effects of nitrite on NOX activity 
and lipid accumulation. On the contrary, raloxifene did not affect the benefits of nitrite 
treatment on either NOX or lipid deposition. Moreover, when NO generation from nitrite was 
detected by electron paramagnetic resonance (EPR) spin trapping, febuxostat attenuated but 
did not fully abolish a previously more prominent NO signal. This evidence suggests a role for 
XOR in bioactivation of nitrite but also indicates that other nitrite-reducing enzymes [213] may 
be at work in this in vitro model. 
In summary, the findings in Study III bring to light a remarkable role of inorganic nitrate and 
nitrite in regulating glucose and lipid metabolism. We also show that these effects are driven 
by NO and therefore, bacterial bioactivation of dietary nitrate is required. Finally, activation of 
the metabolic regulator AMPK and inhibition of NADPH oxidase are suggested as some of the 
molecular drivers in the described protective effects of nitrate and nitrite. 
4.4 STUDY IV 
Germ-free mice are not protected against diet-induced obesity and metabolic 
dysfunction 
 Germ-free mice develop an obese phenotype when fed a Western diet 
If the oral microbiota represents an fundamental player in the biologic effects of nitrate-derived 
NO, the microbes populating our gut are believed indispensable to harvest energy from the diet 
and to direct the accumulation of dietary fats [53,54]. 
However, in Study II of this thesis GF and CONV mice gain weight to a similar extent 
following sustained (6 weeks) consumption of a calorie dense Western diet. This specific 
finding triggered our curiosity, as earlier studies had shown obesity resistance of GF mice [53–
55]. However, when revising the literature in search for explanations to our observations, we 
found that a few others had reported weight gain in GF mice  [62–64]. For these reasons, we 
decided to further investigate whether the microbiota is indeed required for fat storage, hence 
the development of obesity. To do so, we used the same mouse strain and Western diet as in 
the original study [53] reporting obesity resistance in GF mice. 
Thus, aged-matched GF and CONV mice received a Western diet for 16 weeks and body 
weight, food and water consumption were monitored weekly. During this time, both groups of 
mice progressively gained weight to a similar extent (Figure 13A). By the end of the dietary 




13B). These observations were confirmed by body composition analyses (Figure 13C) and 
occurred despite similar food and water intake in the GF and CONV groups (Figure 13D). 
 
Figure 13. Body weight (A) and body weight gain from baseline (B) of CONV (n=6) and GF mice (n=10) during 
16 weeks on a Western diet (WD). Body composition (C) and cumulative food and water intake (D) of GF (n=3) 
and CONV mice (n=4) fed a regular rodent diet or a WD for 16 weeks. Data are shown as mean ± SD (A; B) or ± 
SEM (C; D). p values were calculated with 2-way ANOVA (A; B). Comparisons CONV + Reg Diet vs CONV + 
WD; GF + Reg Diet vs GF+WD; CONV + WD vs GF + WD were analysed by Mann-Whitney test (C) or t-test 
(D).  
The reason why GF mice are protected from obesity in some studies [53–55] but not in the 
current and some other studies [62–65] appears unclear. Differences in experimental design, 
mouse strain and diets are so far the prevalent hypotheses to explain discrepancies among 
reports [64]. We herein attempted to mimic the original study reporting obesity resistance in 
GF mice [53] by using the same diet and the same mouse strain. Yet, our GF mice became 
obese upon prolonged Western diet consumption. Nonetheless, we should not forget that the 
host-microbiota relationship is still somewhat mysterious, and these discordant findings might 
hide new and interesting information. For instance, GF mice in the first study showed increased 
locomotor activity, as compared to CONV mice [53]. At that time, in 2007, very little was 
known about a microbiota-gut-brain axis. Although our knowledge is still limited, we know 
today that the microbiota modulates normal stress responsivity, anxiety-like behaviours, 




behaviour (and potentially food intake, physical activity and social interactions as a 
consequence), might represent one of the causes for the different outcomes obtained in GF 
mice bred in different facilities. Moreover, even using the same mouse strain, differences in 
genetic background are not to be excluded.  
 Germ-free mice on a Western diet develop impaired glucose metabolism 
In light of the findings above, we decided to study glucose tolerance in our GF and CONV 
mice. Intake of a Western diet increased fasting blood glucose in both groups (Figure 14A) and 
a glucose tolerance test revealed a compromised response to glucose in both GF and CONV 
mice in the Western Diet groups, as compared to untreated controls (Figure 14B; C).  
Figure 14. Fasting blood glucose (A) glucose tolerance test curve (B) and area under the curve (C) of CONV 
(n=4) and GF mice (n=3) fed a regular rodent diet or a Western diet (WD; GF n=6 and CONV n=6) for 16 weeks. 
Data are shown as mean ± SEM. Comparisons are CONV + Reg Diet vs CONV + WD; GF + Reg Diet vs GF+WD; 
CONV + WD vs GF + WD, analysed with two-way ANOVA (B) or Mann-Whitney test (A; C). * CONV + Reg 
Diet vs CONV + WD; # GF + Reg Diet vs GF+WD 
 Germ-free mice on a Western diet develop liver steatosis 
Consistent with the idea that the absence of a microbiota prevents body weight gain and its 
related metabolic impairments, GF mice in previous studies were also shown to be protected 
from liver steatosis [222]. However, from a macroscopic examination of the livers, GF mice 
displayed a clear ectopic lipid accumulation (Figure 15E). When assessing hepatic lipid 
accumulation on a microscopic level by Oil Red O staining, we found that both GF and CONV 
mice fed a Western diet had developed a steatotic-like phenotype (Figure 15A; B). This was 
confirmed by quantification of hepatic triglycerides (Figure 15D). 
Accordingly, the weights of the livers were significantly increased in the animals receiving a 























































































Figure 15. Representative pictures of hepatic tissue stained with Oil Red O (A); quantification of Oil Red O stained 
area (B); liver weight (C); liver triglycerides (D) and representative pictures of livers (E) of CONV (n=4) and GF 
mice (n=3) fed a regular diet or a Western diet (WD; CONV n=6 and GF n=6) for 16 weeks. Data are shown as 
mean ± SEM. Comparisons CONV + Reg Diet vs CONV + WD; GF + Reg Diet vs GF+WD; CONV + WD vs 
GF + WD were analysed with Mann-Whitney test. 
Altogether, we present evidence that the host microbiota is not an indispensable factor for lipid 
accumulation and weight gain. Thus, in otherwise healthy individuals, this is likely primarily 
driven by excessive energy intake and consequently energy imbalance. 
 CPT1 activity is elevated in skeletal muscle of obese germ-free mice 
Carnitine palmitoyl transferase 1 (CPT1) is the rate limiting enzyme for mitochondrial fatty 
acid oxidation and its activity was previously found to be elevated in GF mice as compared to 
colonized mice fed a Western diet [53]. This led to the hypothesis that the microbiota might 
suppress CPT1 activity and thereby promote fat storage. Surprisingly, elevated CPT1 activity 
was observed also in our GF mice fed a Western diet as compared to CONV mice on the same 





The role of fatty acid oxidation in diabetes and obesity appears somewhat unclear. Some studies 
across the literature support the idea that inhibition of fatty acid oxidation might ameliorate 
insulin resistance [223,224] whereas others found its stimulation to elicit the same beneficial 
effects in rodents [225]. Future research should clarify the role of human fatty acid oxidation 
in metabolic diseases.  
5 CONCLUSIONS AND FUTURE PERSPECTIVES 
After the discovery of the nitrate-nitrite-NO pathway in 1994, inorganic nitrate gained 
increasing attention as a dietary means of generating NO bioactivity. Owing to the known 
vasodilatory properties of this small gaseous molecule, researchers immediately started to 
explore the therapeutic value of nitrate supplementation to restore NO homeostasis in 
cardiovascular disease [19,22,226]. In 1995, it was reported that eNOS-/- mice not only develop 
hypertension but also severe metabolic dysfunction [82]. These findings revealed a physiologic 
role of NO that goes beyond the regulation of blood pressure. Indeed, later pioneering studies 
by Larsen and colleagues, proved that boosting NO production via nitrate supplementation 
enhances metabolic efficiency in humans by decreasing resting metabolic rate [227] but also 
oxygen cost during exercise [117], while enhancing mitochondrial efficiency in healthy 
individuals [13].  
Thus, dietary nitrate was emerging as a modulator of metabolic function, holding promise as a 
dietary intervention that promotes and protects overall good health. This idea triggered our 
curiosity about any anti-aging potential of dietary nitrate. Notably, NO synthesis and 
bioavailability decrease during aging [7], when cardiovascular, metabolic and physical 
function decline as well. 
When this work was started in 2016, our group had just shown beneficial effects of nitrate 
supplementation on blood pressure, endothelial function and glucose homeostasis in a rodent 
model of natural aging [74].  However, a straightforward answer on whether diet-derived NO 
could extend health- and lifespan, would only come from longevity studies.  
The tiny insect Drosophila melanogaster enabled us to show that low amounts of inorganic 
dietary nitrite exert a pro-longevity effect in female flies and protect them from age-related 
locomotor decline. In the same study, we indicate that fruit flies effectively reduce nitrite, 
forming NO. In insects like in other species, NO is a key signaling molecule essential for 
development [228] and a variety of life-indispensable processes [229]. Thus, based on our 
findings, it is tempting to speculate that backup NO generation from exogenous nitrite and 
nitrate might represent an evolutionary preserved mechanism, reinforcing the idea of NO as a 
crucial molecule for life. What is more to this, is the extraordinary contribution of the fly 




The obligatory role of the mammalian microbiota in bioactivation of dietary nitrate is another 
key finding of this thesis. Using germ-free mice, we unequivocally show that bacteria represent 
the sine qua non for both the cardiovascular and metabolic benefits of dietary nitrate.  
Together, these studies bring to light an ancient story of generosity between the host and its 
microbiota, whereby bacteria are provided with important substrates (nitrate and nitrite) for 
their own respiration and, in a true symbiotic fashion, give back to the host a tiny gaseous 
molecule crucial for life-long health: nitric oxide. 
Further, we add new knowledge on the potential of dietary nitrate in preserving metabolic 
health, both when this is threatened by unhealthy dietary habits but also during the natural 
process of aging. To this regard, one interesting observation in this thesis is the sexual 
dimorphism in the pro-longevity effects of nitrite. In 2018, Kapil and colleagues reported 
increased nitrate reduction activity in females, both at baseline and after nitrate ingestion. This 
suggests that the oral microbiota in females might be a more efficient nitrate reducer. 
Nonetheless, the oral microbiota did not seem to differ between sexes in the Kapil study [230], 
although the scientific community tends to agree on sex-differences in microbial composition 
[231,232]. Clarifying whether a sexual dimorphism in nitrate reductase capacity is to be 
attributed partly or completely to the oral flora might provide useful information on how to 
maximize the benefits of nitrate supplementation. For instance, specific probiotic interventions 
could be optimized to ensure efficient nitrate bioactivation in otherwise non-responder subjects. 
These might also be of value for older adults, patients with specific oral diseases or subjects 
chronically treated with medications that could partly deplete or modify the oral microbiota.  
In the past two decades, the gut microbiota has emerged as a crucial regulator of our 
metabolism and a key player in the onset of obesity and T2D [233]. However, in Study IV we 
provide evidence that calorie dense diets likely remain the main drivers of such metabolic 
disorders. Vegetable and fruit-rich diets - thus nitrate-rich diets - are known for their broad 
health benefits [71] and salutary impact on the gut microbiota [73,234]. Consequently, one 
would expect that, if any, the action of inorganic nitrate and nitrite in dietary amounts would 
positively shape gut bacteria and favour metabolic health in humans. Indeed, recent studies 
have already suggested a previously unbelieved interaction between the gut microbiota and 
inorganic nitrate, apparently with interesting implications in the salutary effects of this anion 
[78,80,81,235].  
Whether or not dietary nitrate directly shapes the gut microbiota, one exciting opportunity 
would be to investigate whether this anion could indirectly produce such effect. Indeed, 
physical exercise has been shown to positively impact on the gut microbiota [236], with 
beneficial implications both in sports performance [237] and general health [236]. A possibility 
could be that nitrate supplementation, via its established exercise-enhancing abilities, might 
shape and maintain a “healthy gut microbiota” providing further protection against metabolic 




nitrate intake paired with exercise, might synergize in regulating blood glucose levels in 
diabetic patients.  
In summary, the studies in this thesis bring to light novel and beneficial metabolic effects of 
inorganic nitrate and nitrite, two anions that have long been regarded as detrimental for our 
health. Importantly, this work also highlights the idea that protection of metabolic homeostasis 
by diet-derived NO involves various organ systems, eventually leading to overall promotion of 
health and perhaps even extension of the healthspan. Finally, our work shows that commensal 
bacteria play a key role in mediating the health benefits of dietary nitrate. Although, 
surprisingly, we found no support for the reigning dogma stating that gut bacteria drive diet-
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